Methylone safety study for post-traumatic stress
About this title
Read the official source — NCT06215261Researchers studied Methylone to find out how it affected post-traumatic stress symptoms in people with PTSD.
Understand this study
What did researchers investigate?
Researchers studied Methylone to find out how it affected post-traumatic stress symptoms in people with PTSD.
Who was this study for?
This study was for people with PTSD. Listed age limits: 18 years to 70 years. Other eligibility criteria applied.
- Listed locations
- Lauderhill and 11 more locationsSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
- Recruitment status
- Completed
- Enrollment listed in the registry
- 62
- Sponsor
- Transcend Therapeutics
- Sponsor type
- Biotech company
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States, Australia, United Kingdom
- Age range
- From 18 Years to 70 Years
- Official registry ID
- NCT06215261
- Official title
Show the full official title
An Evaluation of the Safety and Efficacy of Methylone for the Treatment of PTSD IMPACT-2 (Investigation of Methylone for Post-Traumatic Stress Disorder [PTSD])
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
Lauderhill, United States · Maitland, United States · Orlando, United States
8 more locations
- Chicago, United States
- Rockville, United States
- Las Vegas, United States
- Draper, United States
- Bellevue, United States
- Hawthorn, Australia
- Melbourne, Australia
- London, United Kingdom
Interested in joining this study?
Questions about this study
What did researchers investigate?
Researchers studied Methylone to find out how it affected post-traumatic stress symptoms in people with PTSD.
Who is behind this study?
The study sponsor is Transcend Therapeutics.
Did this study involve medication?
Yes. The study involved medication, including Methylone.
Who was this study for?
This study was for people with PTSD. Listed age limits: 18 years to 70 years. Other eligibility criteria applied.
